Shinva Medical Instrument Co.,Ltd. (SHA:600587)
China
· Delayed Price · Currency is CNY 15.31
+0.08 (0.53%)
May 23, 2025, 2:45 PM CST
Shinva Medical Instrument Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 9,643 | 9,864 | 9,904 | 9,072 | 9,343 | 8,994 | Upgrade
|
| Other Revenue | 156.13 | 156.13 | 108 | 210.16 | 139.3 | 156.93 | Upgrade
|
| Revenue | 9,800 | 10,021 | 10,012 | 9,282 | 9,482 | 9,151 | Upgrade
|
| Revenue Growth (YoY) | -2.99% | 0.09% | 7.87% | -2.11% | 3.62% | 4.38% | Upgrade
|
| Cost of Revenue | 7,315 | 7,461 | 7,394 | 6,863 | 7,200 | 7,088 | Upgrade
|
| Gross Profit | 2,484 | 2,559 | 2,618 | 2,419 | 2,282 | 2,063 | Upgrade
|
| Selling, General & Admin | 1,274 | 1,291 | 1,344 | 1,349 | 1,324 | 1,300 | Upgrade
|
| Research & Development | 446.64 | 436.08 | 443.37 | 401.27 | 295.98 | 197.53 | Upgrade
|
| Other Operating Expenses | 54.51 | 68.78 | 76.99 | 67.62 | 59.36 | 13.13 | Upgrade
|
| Operating Expenses | 1,829 | 1,865 | 1,948 | 1,846 | 1,714 | 1,593 | Upgrade
|
| Operating Income | 655.24 | 694.8 | 670.31 | 572.27 | 567.33 | 470.58 | Upgrade
|
| Interest Expense | -42.01 | -44.79 | -47.07 | -56.93 | -76.26 | -121.45 | Upgrade
|
| Interest & Investment Income | 85.63 | 95.57 | 110.96 | 61.75 | 126.94 | 58.98 | Upgrade
|
| Currency Exchange Gain (Loss) | 4.14 | 4.14 | 7.54 | 10.37 | -0.99 | -5.48 | Upgrade
|
| Other Non Operating Income (Expenses) | -25.26 | -21.91 | -9.44 | -4.17 | -12.03 | -24.24 | Upgrade
|
| EBT Excluding Unusual Items | 677.73 | 727.8 | 732.3 | 583.29 | 604.99 | 378.39 | Upgrade
|
| Impairment of Goodwill | -15.22 | -15.22 | -11.49 | - | - | -21.67 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 12.54 | -57.21 | 60.71 | -0.17 | Upgrade
|
| Gain (Loss) on Sale of Assets | -2.49 | -1.51 | 4.4 | 0.48 | -0.35 | -3.73 | Upgrade
|
| Asset Writedown | 1.02 | - | -0.73 | - | -0.62 | - | Upgrade
|
| Legal Settlements | - | - | - | - | -0.57 | -10.65 | Upgrade
|
| Other Unusual Items | 84.59 | 84.59 | 1.57 | 49.53 | 53.87 | 3.13 | Upgrade
|
| Pretax Income | 745.63 | 795.66 | 738.58 | 576.09 | 718.03 | 345.3 | Upgrade
|
| Income Tax Expense | 107.52 | 103.76 | 62.08 | 49.18 | 162.01 | 105.9 | Upgrade
|
| Earnings From Continuing Operations | 638.1 | 691.9 | 676.5 | 526.91 | 556.02 | 239.4 | Upgrade
|
| Minority Interest in Earnings | 2.93 | -0.29 | -22.5 | -26.84 | 0.47 | -5.26 | Upgrade
|
| Net Income | 641.03 | 691.61 | 654 | 500.07 | 556.49 | 234.14 | Upgrade
|
| Net Income to Common | 641.03 | 691.61 | 654 | 500.07 | 556.49 | 234.14 | Upgrade
|
| Net Income Growth | -4.11% | 5.75% | 30.78% | -10.14% | 137.68% | -72.82% | Upgrade
|
| Shares Outstanding (Basic) | 605 | 607 | 595 | 529 | 528 | 525 | Upgrade
|
| Shares Outstanding (Diluted) | 605 | 607 | 600 | 529 | 528 | 525 | Upgrade
|
| Shares Change (YoY) | -1.21% | 1.11% | 13.53% | 0.08% | 0.64% | -0.65% | Upgrade
|
| EPS (Basic) | 1.06 | 1.14 | 1.10 | 0.95 | 1.05 | 0.45 | Upgrade
|
| EPS (Diluted) | 1.06 | 1.14 | 1.09 | 0.95 | 1.05 | 0.45 | Upgrade
|
| EPS Growth | -2.94% | 4.59% | 15.20% | -10.21% | 136.17% | -72.64% | Upgrade
|
| Free Cash Flow | -0.66 | 29.85 | 494.34 | 140.47 | 1,128 | 906.78 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | 0.05 | 0.82 | 0.27 | 2.14 | 1.73 | Upgrade
|
| Dividend Per Share | 0.250 | 0.250 | 0.385 | 0.115 | 0.115 | 0.077 | Upgrade
|
| Dividend Growth | -35.00% | -35.00% | 233.28% | - | 50.07% | - | Upgrade
|
| Gross Margin | 25.35% | 25.54% | 26.15% | 26.06% | 24.06% | 22.55% | Upgrade
|
| Operating Margin | 6.69% | 6.93% | 6.69% | 6.17% | 5.98% | 5.14% | Upgrade
|
| Profit Margin | 6.54% | 6.90% | 6.53% | 5.39% | 5.87% | 2.56% | Upgrade
|
| Free Cash Flow Margin | -0.01% | 0.30% | 4.94% | 1.51% | 11.90% | 9.91% | Upgrade
|
| EBITDA | 840.78 | 880.63 | 857.33 | 761.5 | 744.07 | 649.17 | Upgrade
|
| EBITDA Margin | 8.58% | 8.79% | 8.56% | 8.20% | 7.85% | 7.09% | Upgrade
|
| D&A For EBITDA | 185.54 | 185.84 | 187.03 | 189.23 | 176.74 | 178.6 | Upgrade
|
| EBIT | 655.24 | 694.8 | 670.31 | 572.27 | 567.33 | 470.58 | Upgrade
|
| EBIT Margin | 6.69% | 6.93% | 6.69% | 6.17% | 5.98% | 5.14% | Upgrade
|
| Effective Tax Rate | 14.42% | 13.04% | 8.40% | 8.54% | 22.56% | 30.67% | Upgrade
|
| Revenue as Reported | 9,800 | 10,021 | 10,012 | 9,282 | 9,482 | 9,151 | Upgrade
|
| Advertising Expenses | - | 20.65 | 24.19 | 22.66 | 38.05 | 31.12 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.